20 articles, transcripts, and reports
Arrowhead Pharmaceuticals, Inc (NASDAQ: ARWR) Q2 2025 Earnings Call dated May. 12, 2025 Corporate Participants: Vince Anzalone — Vice President, Investor Relations Christopher Anzalone —…
Arrowhead Pharmaceuticals, Inc (NASDAQ: ARWR) Q3 2025 Earnings Call dated Aug. 07, 2025 Corporate Participants: Vincent Anzalone — Vice President and Head of Investor Relations…
Arrowhead Pharmaceuticals, Inc (NASDAQ: ARWR) Q4 2025 Earnings Call dated Nov. 25, 2025 Corporate Participants: Vince Anzalone — Vice President, Investor Relations Christopher Anzalone —…
Arrowhead Pharmaceuticals, Inc (NASDAQ: ARWR) Q3 2022 Earnings Conference
Arrowhead Pharmaceuticals, Inc (NASDAQ: ARWR) Q1 2022 Earnings Conference
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) Q4 2021 earnings call, dated Nov. 22, 2021. Corporate Participants: Vince Anzalone — Vice President of Investor Relations Christopher Anzalone — President and Chief…
Arrowhead Pharmaceuticals, inc (NASDAQ: ARWR) Q3 2021 Earnings Conference
Arrowhead Pharmaceuticals, inc (NASDAQ: ARWR) Q2 2021 Earnings Conference
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) Q1 2020 Earnings Conference Call February 05, 2020 Corporate participants: Vincent Anzalone — Vice President of Investor Relations Christopher Anzalone —…
— Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported earnings of 69 cents per share during fiscal year 2019, compared to a loss of 65 cents per…
